References
- Andrews E, Seaman WT, Webster-Cyriaque J (2009). Oropharyngeal carcinoma in non-smokers and non-drinkers: a role for HPV. Oral Oncol, 45, 486-91. https://doi.org/10.1016/j.oraloncology.2008.07.008
- Chen W, Zhang X, Molijn A, et al (2009). Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18. Cancer Causes Control, 20, 1705-13. https://doi.org/10.1007/s10552-009-9422-z
- D'Souza G, Kreimer AR, Viscidi R, et al (2007). Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med, 356, 1944-56. https://doi.org/10.1056/NEJMoa065497
- Dayyani F, Etzel CJ, Liu M, et al (2010). Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol, 2, 15. https://doi.org/10.1186/1758-3284-2-15
- Fakhry C, Westra WH, Li S, et al (2008). Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst, 100, 261-9. https://doi.org/10.1093/jnci/djn011
- Gillison ML, D'Souza G, Westra W, et al (2008). Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst, 100, 407-20. https://doi.org/10.1093/jnci/djn025
- Gillison ML, Koch WM, Capone RB, et al (2000). Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst, 92, 709-20. https://doi.org/10.1093/jnci/92.9.709
- Hafkamp HC, Manni JJ, Haesevoets A, et al (2008). Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer, 122, 2656-64. https://doi.org/10.1002/ijc.23458
- Herrero R, Castellsague X, Pawlita M, et al (2003). Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst, 95, 1772-83. https://doi.org/10.1093/jnci/djg107
- Hong AM, Dobbins TA, Lee CS, et al (2010). Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br J Cancer, 103, 1510-7. https://doi.org/10.1038/sj.bjc.6605944
- Joo YH, Jung CK, Sun DI, et al (2011). High-risk human papillomavirus and cervical lymph node metastasis in patients with oropharyngeal cancer. Head Neck.
- Kleter B, van Doorn LJ, Schrauwen L, et al (1999). Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol, 37, 2508-17.
- Klussmann JP, Weissenborn SJ, Wieland U, et al (2001). Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer, 92, 2875-84. https://doi.org/10.1002/1097-0142(20011201)92:11<2875::AID-CNCR10130>3.0.CO;2-7
- Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005). Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev, 14, 467-75. https://doi.org/10.1158/1055-9965.EPI-04-0551
- Kumar B, Cordell KG, Lee JS, et al (2007). Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking. Int J Radiat Oncol Biol Phys, 69, S109-11.
- Kuo KT, Hsiao CH, Lin CH, et al (2008). The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma-molecular basis and predicting favorable outcome. Mod Pathol, 21, 376-86. https://doi.org/10.1038/modpathol.3800979
- Licitra L, Perrone F, Bossi P, et al (2006). High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol, 24, 5630-6. https://doi.org/10.1200/JCO.2005.04.6136
- Lill C, Kornek G, Bachtiary B, et al (2011). Survival of patients with HPV-positive oropharyngeal cancer after radiochemotherapy is significantly enhanced. Wien Klin Wochenschr, 123, 215-21. https://doi.org/10.1007/s00508-011-1553-z
- Mak-Kregar S, Hilgers FJ, Levendag PC, et al (1995). A nationwide study of the epidemiology, treatment and survival of oropharyngeal carcinoma in The Netherlands. Eur Arch Otorhinolaryngol, 252, 133-8. https://doi.org/10.1007/BF00178098
- Munoz N, Bosch FX, de Sanjose S, et al (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348, 518-27. https://doi.org/10.1056/NEJMoa021641
- Nasman A, Attner P, Hammarstedt L, et al (2009). Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer, 125, 362-6. https://doi.org/10.1002/ijc.24339
- Posner MR, Lorch JH, Goloubeva O, et al (2011). Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial. Ann Oncol, 22, 1071-7. https://doi.org/10.1093/annonc/mdr006
- Shiboski CH, Schmidt BL, Jordan RC (2005). Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer, 103, 1843-9. https://doi.org/10.1002/cncr.20998
- Smith EM, Ritchie JM, Summersgill KF, et al (2004). Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer, 108, 766-72. https://doi.org/10.1002/ijc.11633
- St Guily JL, Jacquard AC, Pretet JL, et al (2011). Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France--The EDiTH VI study. J Clin Virol, 51, 100-4. https://doi.org/10.1016/j.jcv.2011.03.003
- Tachezy R, Klozar J, Rubenstein L, et al (2009). Demographic and risk factors in patients with head and neck tumors. J Med Virol, 81, 878-87. https://doi.org/10.1002/jmv.21470
- Weinberger PM, Yu Z, Haffty BG, et al (2006). Molecular classification identifies a subset of human papillomavirus-- associated oropharyngeal cancers with favorable prognosis. J Clin Oncol, 24, 736-47. https://doi.org/10.1200/JCO.2004.00.3335
- Worden FP, Kumar B, Lee JS, et al (2008). Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol, 26, 3138-46. https://doi.org/10.1200/JCO.2007.12.7597
Cited by
- Increase in the Rate of HPV Positive Oropharyngeal Cancers During 1996-2011 in a Case Study in Turkey vol.14, pp.10, 2013, https://doi.org/10.7314/APJCP.2013.14.10.6065
- Epigenetic Mechanisms in Penile Carcinoma vol.14, pp.6, 2013, https://doi.org/10.3390/ijms140610791
- Predictive value of human papillomavirus in oropharyngeal carcinoma treated with radiotherapy: An updated systematic review and meta-analysis of 30 trials vol.36, pp.5, 2013, https://doi.org/10.1002/hed.23351
- Lack of Association between High-risk Human Papillomaviruses and Oral Squamous Cell Carcinoma in Young Japanese Patients vol.15, pp.10, 2014, https://doi.org/10.7314/APJCP.2014.15.10.4135
- Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma vol.33, pp.1, 2014, https://doi.org/10.1186/s13046-014-0100-y
- Significance of p16 Positive Expression in Oropharyngeal Cancers vol.15, pp.23, 2015, https://doi.org/10.7314/APJCP.2014.15.23.10289
- Expression and Response to Therapy and Survival in Selected Head and Neck Cancers vol.16, pp.1, 2015, https://doi.org/10.7314/APJCP.2015.16.1.253
- A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancer vol.33, pp.6, 2015, https://doi.org/10.1007/s10637-015-0293-8
- Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population vol.11, pp.10, 2016, https://doi.org/10.1371/journal.pone.0164491
- Prevalence and Determinants of Oral Human Papillomavirus Infection in 500 Young Adults from Italy vol.12, pp.1, 2017, https://doi.org/10.1371/journal.pone.0170091